XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net revenues $ 9,085,826 $ 10,085,926 $ 27,432,376 $ 30,199,441
Costs and expenses:        
Cost of products sold 1,323,013 1,765,590 4,609,499 4,536,628
Selling and marketing 4,397,480 4,743,142 12,800,469 13,692,535
Research and development 1,306,095 1,924,768 3,523,535 4,569,476
General and administrative 2,675,380 2,343,855 7,800,435 7,212,731
Amortization 1,078,290 1,175,174 3,288,808 3,563,493
Total costs and expenses 10,780,258 11,952,529 32,022,746 33,574,863
Operating loss (1,694,432) (1,866,603) (4,590,370) (3,375,422)
Interest income 69,190 98,603 227,777 205,854
Other income 0 0 0 2,828,871
Other income - settlement 0 475,000 0 475,000
Other income - insurance proceeds 237,089 346,800 237,089 346,800
Interest expense (137,374) (110,081) (382,247) (489,069)
Loss before income taxes (1,525,527) (1,056,281) (4,507,751) (7,966)
Income tax expense (11,442) (6,938) (34,327) (20,813)
Net loss (1,536,969) (1,063,219) (4,542,078) (28,779)
Net loss (income) at subsidiary attributable to noncontrolling interests (7,112) 13,921 (33,878) 43,865
Net income (loss) attributable to common shareholders $ (1,544,081) $ (1,049,298) $ (4,575,956) $ 15,086
Earnings (loss) per share attributable to common shareholders        
Basic (in USD per share) $ (0.11) $ (0.07) $ (0.32) $ 0
Diluted (in USD per share) $ (0.11) $ (0.07) $ (0.32) $ 0
Weighted-average shares outstanding        
Basic (in shares) 14,052,754 14,277,229 14,089,496 14,343,560
Diluted (in shares) 14,052,754 14,277,229 14,089,496 14,521,600